Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, Ante Markovinović, Stephanie Coward, Joseph W. Windsor, Léa Caplan, R Ingram, Carmen Charlton, Jamil N. Kanji, Graham Tipples, Jessalyn K. Holodinsky, Çharles N. Bernstein, Douglas J. Mahoney, Sasha Bernatsky, Eric I. Benchimol, Gilaad G. Kaplan
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Inflammatory bowel diseaseCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSerologyCoronavirus InfectionsInflammatory Bowel DiseasesVirologyDiseaseImmunologyInternal medicineAntibodyInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmunodeficiency and Autoimmune Disorders